Immediate Impact

1 by Nobel laureates 58 standout
Sub-graph 1 of 23

Citing Papers

The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology
2024 Standout
The two sides of chromosomal instability: drivers and brakes in cancer
2024 Standout
1 intermediate paper

Works of Thomas J. Semrad being referenced

A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer
2022
Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors
2015

Author Peers

Author Last Decade Papers Cites
Thomas J. Semrad 387 231 161 253 51 864
Emanuele Naglieri 327 192 140 207 40 1.0k
Kefeng Wang 298 151 183 230 40 867
Herbert Stöger 549 254 155 164 68 1.1k
Simon J. Hollingsworth 343 146 216 340 54 923
Alessandra Felici 475 351 192 291 49 1.1k
Anastasios Dimou 474 306 108 195 67 781
Matteo Brighenti 610 305 63 177 38 839
Luciano Canobbio 499 186 156 160 52 791
C. C. Zielinski 259 152 56 152 45 907
Francesco De Rosa 671 155 99 284 56 1.1k

All Works

Loading papers...

Rankless by CCL
2026